COMMONWEALTH OF KENTUCKY CABINET FOR HEALTH AND FAMILY SERVICES DEPARTMENT FOR MEDICAID SERVICES PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE MEETING Capitol Annex -Room[removed]Capital Avenue Frankfort, Kentucky 40601

First Page		Document Content
Date: 2014-11-27 12:27:26 Cannabinoids Drug discovery Piperidines Organofluorides Vandetanib Tetrahydrocannabinol 5-HT3 antagonist Chemistry Antiemetics Organic chemistry		COMMONWEALTH OF KENTUCKY CABINET FOR HEALTH AND FAMILY SERVICES DEPARTMENT FOR MEDICAID SERVICES PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE MEETING Capitol Annex -Room[removed]Capital Avenue Frankfort, Kentucky 40601 Add to Reading List Source URL: chfs.ky.gov Download Document from Source Website File Size: 33,52 KB Share Document on Facebook

	P11444 - ASCO2014 MEC and HEC DocID: 1a4Ek - View Document
	P11444 - ASCO2014 MEC and HEC DocID: 19OCx - View Document
	Astellas Receives Approval for a Supplemental New Drug Application for Irribow®/Irribow® OD, a Treatment of Diarrhea-predominant Irritable Bowel Syndrome, in Japan Tokyo, May 26, Astellas Pharma Inc. (“Astella DocID: 19AF1 - View Document
	P11444 - ASCO2014 MEC and HEC DocID: 199Dl - View Document
	P11444 - ASCO2014 MEC and HEC DocID: 1987o - View Document